Zantac Cancer Lawsuit

People were taking what they thought were safe antacid pills but may be been ingesting high levels of a carcinogen instead without knowing it

Quick Facts

  • Biggest Award: First Case Outcomes Still Pending
  • Number of Cases: 140 Cases as of March 2020
  • Medication Introduction Date: 1981
  • Intended Use: OTC ranitidine is commonly used to relieve and prevent heartburn. Prescription strengths are also used to treat and prevent more serious ulcers in the stomach and intestines.
  • Side-Effects: Exposure to alarming high levels of a cancer causing chemical NDMA

On This Page

What You Need to Know

What Is The Zantac Case All About
The makers of the popular antacid drug Zantact are accused of creating and marketing a medication they knew contained the cancer-causing chemical (NDMA) without disclosing the risks to consumers or the government. They must be held accountable for their actions.

Who Is Impacted by this Case
Anyone who has used Zantac on a regular basis for any extended period of time would be impacted by this. Individuals who have also been diagnosed with cancer should check for eligibility.

When was Zantac Introduced
The generic drug ranitidine and Zantac were both introduced in the United states in 1981 as a prescription and over the counter drugs. When the drug was first introduced it was aggressively promoted to both doctors and the general public and Zantac went on to become one of the best-selling drugs in pharmaceutical history.

Why Has Zantac Been Recalled
The FDA along with two other private labs using FDA approved testing has found that over time the chemical NDMA rises in the drug ranitidine (the main drug used in Zantac) to dangerous levels that are not safe for the human body.

How To Fight Back Against Zantac
To see if you or a loved one qualify to fight against Zantac, start by taking a free evaluation to check eligibility for compensation.

What is the Zantac Lawsuit About

The popular antacid drug Zantac’s main ingredient ranitidine has been found to contain very high levels of a cancer-causing chemical called N-Nitrosodimethylamine (NDMA). In addition there is now evidence suggesting that while the big pharma companies who make Zantac were making unpredendent profits (it was the first drug to ever generate a billion dollars in annual sales) the companies became aware that there was a link to cancer and hid it from consumers for years.

When Was Zantac Cancer Risk Discovered?

In September 2019, the U.S. Food and Drug Administration first issued a public safety warning about possible cancer risks from Zantac after it became aware of results from an independent laboratory that found high levels of NDMA in ranitidine. At the time, the agency said it did not have enough scientific evidence to recommend whether individuals should continue or stop taking ranitidine medicines. However now after conducting its own research and evaluation similar results were found by the FDA and in April the agency ordered the drug to be removed from the market completely.

What is NDMA?

N-Nitrosodimethylamine (“NDMA”) is a chemical that is usually created as a byproduct of either a natural chemical process in nature or of a manufacturing process. It can be found in small traces in many products and foods around the world. The U.S. Food and Drug Administration (FDA), the Environmental Protection Agency (EPA), and the World Health Organization (WHO) all classify NDMA as a cancer-causing chemical yet NDMA in low doses is not considered dangerous (The FDA has set the acceptable daily intake of NDMA at 96 nanograms). However in high dosages, such as the ones recently found in Zantac, the chemical is considered very dangerous to the human body.

What Are The Cancer Risks of NDMA?

There have been many studies over the last 30 years showing a link between NDMA and cancer. The International Agency for Cancer Research (IARC) unit of the World Health Organization reviewed all studies and warns that NDMA is considered a carcinogenic (cancer causing) in humans. The agency found that NDMA is “carcinogenic in all animal species tested” and noted that the metabolism of NDMA by humans and animals is similar.

Exposure to NDMA in ranitidine has been linked to a number of cancers including Stomach cancer, Colon or Intestinal cancer, Kidney cancer, Breast Cancer, Liver Cancer, Bladder cancer, Liver cancer, Prostate cancer, Lung Cancer, Brain cancer, Pancreatic cancer, Prostate cancer, and Rectal cancer. .

NDMA Dangers in Zantac

What Are The Dangers?

The major risks of cancer and NDMA have to do with the levels of the chemical found in the drug. Both the FDA and other third party labs using FDA approved testing found NDMA levels in ranitidine to be “alarming high”. The testing done by independent pharmacy Valisure’s lab found the levels to be more than 3,000 times higher than the FDA recommended daily dose.

The FDA has agreed that the levels of NDMA in Zantac and other ranitidine products increase over time to an unacceptable level for daily intake yet the FDA calls the high NDMA levels found in Zantac an “impurity”. The agency says that NDMA was present in both the finished drug product samples and the active pharmaceutical ingredients (APIs). But two other independent labs using FDA approved testing does not show this. According to their tests NDMA is not added instead it is formed as a by-product of the chemical process that happens when the drug sits out. Emery Pharma testing shows that NDMA can increase during storage, especially if the drug is exposed to high heat and even while it remains in the package. In addition the Valisure testing results show that NDMA is actually formed in the body upon consumption. In September 2019 they sent a citizen petition to the FDA warning of their findings.

New Research Discoveries

A Stanford University research study from 2016 further supports the results made by Valisure. Urine samples were tested from adults 24 hours before and after ingestion of a standard dose of 150 mg of ranitidine. The results found that levels of NDMA in the urine increased 400-fold, from 110 ng to 47,600 ng. These levels, the researchers believe, show there has been a large underestimation of the actual NDMA exposure in the body, since only a small fraction of the NDMA is actually excreted in the urine.

Clearly more investigation and transparency is needed by the FDA and other governing bodies into the cancer risks of NDMA in ranitidine drugs. Yet based on the knowledge currently available there is enough evidence to show that NDMA levels in Zantac are not safe.

Who Is Impacted By This?

There are potentially millions of people affected by this product. This case has such a high reach because Zantac was a very popular and easily accessible drug. Millions of Americans have been using Zantac and its generic equivalents daily for years to reduce acid reflux. It has been available both over the counter and by prescription. However those diagnosed with specific types of cancer that are closely linked to NDMA will have a more direct impact.
Zantac Lawsuit

How Have Affected People Fought Back?

As much of the information surrounding Ranitidine is relatively new, cases against Zantac have only just begun. As of March 2020 there are 140 cases with thousands of people filing suits against Zantac, however most legal experts believe that this is only the beginning and expect a huge number of Zantac lawsuits getting filed over the next few years.

Joining a lawsuit would help hold the makers of Zantac accountable for not protecting consumer rights and would push for the strengthening of consumer protections in the future which would include rules for updating labelling on drugs and recalling other drugs with problematic levels of NDMA. In addition it will help those who have suffered harm from the company’s unethical behaviour receive compensation.

How Can I Join The Lawsuit?

Take a free evaluation to determine eligibility for taking action. You or a loved one must meet the following criteria:

  1. Have Taken Zantac
  2. Diagnosed with one of the following Bladder cancers: Brain cancer, Breast cancer, Colon or intestinal cancer, Kidney cancer, Liver cancer, Lung cancer, Pancreatic cancer, Prostate cancer, Rectal cancer, Stomach cancer


If eligible, gather and collect relevant paperwork including:

  1. Health and Medical Records
  2. Records of Zantac use and purchases
  3. Any relevant testimony from peers and family members


Discuss the lawsuit potential with a team member

  1. Receive and review a contingency agreement to join a lawsuit
  2. If approved, sign the contingency agreement
  3. A specialized lawyer will help and guide you in the fight against Zantac
  4. There are no fees for starting the process and signing the contingency agreement. Fees will only be assessed in the event of a successful outcome from the lawsuit.

Need Help?

Zantac Case FAQs

Select Justice is an advocacy group made up of journalists, investigators and technology professionals committed to helping injured individuals seek justice. We believe that everyone is entitled to know their legal rights and how to use them.
We use our expertise to help people injured by dangerous & defective products, medical malpractice, and employer negligence understand and exercise their rights by discussing their situations and referring them to qualified law firms within our network.

No, Select Justice is not a law firm and is not qualified to give any legal advice. We advocate for those individuals who have been harmed or injured by assisting them with understanding the cause of their situation, identifying who may be responsible, and helping them take steps to pursue justice against the wrongdoers.

We simplify the legal process for you and give you easy access to qualified lawyers who will help bring you justice and compensation. With our vast network we ensure that you are matched with an expert legal team suited specifically for your unique case needs.
If you or a loved one was harmed by using Zantac, please fill out a short questionnaire that helps us understand if you are qualified to pursue compensation against the wrongdoers. After qualifying, a Select Justice team member will call to collect some more detailed information.  Following a short conversation, the team member will be able to point you in the direction of follow up actions. You may be asked to provide specific details or more information and documentation related to your injury. If qualified, you will be referred to a capable legal team that can help you pursue justice.

Select Justice is an absolutely free service that does not charge any money to advocate for injured individuals. During no part of the process with Select Justice will users be required to provide any monetary compensation or payment to the company.

If you choose to take legal action with our recommended lawyers a contingency agreement will be sent to you to review and sign and you will then begin working with a lawyer who will be dedicated to your case and bringing you justice. There are no fees for starting the process and signing the contingency agreement. Fees will only be assessed in the event of a successful outcome from the claim.
We take matters of personal privacy very seriously. When you share you personal and private information with our team of professionals, we take many special measures to protect your privacy. We are HIPAA-compliant to ensure any medical records you share with us are secure. Additionally, we follow other best practices in the areas of information security to assure your information is safe from prying eyes.

You can email us info@selecjustice.com or call to get in touch with a team member. We are here to help you and loved ones advocate for justice. Feel free to send us any questions you might have, either about an injury or the process for pursuing justice so we can help you exercise your rights.

Select Justice

Join the Zantac Lawsuit

Evaluation is confidential and free and fees are paid only if you get compensation